Life ScienceCompany
ANI Pharmaceuticals M&A Summary
ANI Pharmaceuticals has acquired 15 companies, including 4 in the last 5 years. A total of 1 acquisition came from private equity firms.
ANI Pharmaceuticals’ largest acquisition to date was in 2024, when it acquired Alimera Sciences for $381M. ANI Pharmaceuticals has acquired in 6 different US states, and 4 countries. The Company’s most targeted sectors include life science (87%) and medical products (14%).
ANI Pharmaceuticals Business Overview
Where is ANI Pharmaceuticals headquartered?
ANI Pharmaceuticals is headquartered in Baudette, Minnesota.
What is ANI Pharmaceuticals’ revenue?
ANI Pharmaceuticals disclosed revenue of 487M USD for 2023 and 316M USD for 2022.
How many employees does ANI Pharmaceuticals have?
ANI Pharmaceuticals has 642 employees.
What sector is ANI Pharmaceuticals in?
ANI Pharmaceuticals is a life science company.
When was ANI Pharmaceuticals founded?
ANI Pharmaceuticals was founded in 2001.
M&A Summary
-
M&A Total Activity15
- M&A Buy Activity15
- Total Sectors Invested 2
- Total Countries Invested 4
- M&A Buy/Sell Connections 11
- M&A Advisors 8